Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris. 

The worldwide stroke rate has been decreasing over time, but the population is aging and growing at such a rapid rate that stroke-related mortality is still expected to rise. 

The new study, based on “the largest cohort to date of Harmony TPV recipients," was published in JACC: Cardiovascular Interventions.

Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

A research lab led by a veteran cardiothoracic surgeon found that ChatGPT—particularly the GPT-4 model—could 'potentially revolutionize' training in the years ahead. 

Click through a series of photos of cardiology-related technologies from the world's largest health IT conference.

The Israel-headquartered firm specializes in AI-based ultrasound image examination, scoring its ninth U.S. FDA clearance in February. 

The USPSTF’s update suggests that women should screen every other year, but the group's own modeling studies have cited the benefits of annual screening.